Skip to main content
Journal cover image

HIV vaccine development at Duke University Medical Center.

Publication ,  Journal Article
Haynes, BF; Liao, HX; Staats, HF; Alam, MS; Weinhold, KJ; Montefiori, DC
Published in: Immunol Res
2000

With the AIDS epidemic continuing to spread throughout the world, development of a safe, practical, and effective HIV vaccine is a national priority. HIV vaccine research efforts are currently targeted towards design of HIV immunogens that induce both cellular and humoral immunity. This brief review summarizes ongoing work at the Duke University School of Medicine on HIV vaccine development.

Duke Scholars

Published In

Immunol Res

DOI

ISSN

0257-277X

Publication Date

2000

Volume

22

Issue

2-3

Start / End Page

263 / 269

Location

United States

Related Subject Headings

  • Vaccines, Synthetic
  • T-Lymphocytes, Cytotoxic
  • Peptide Fragments
  • North Carolina
  • Molecular Sequence Data
  • Immunology
  • Humans
  • HLA Antigens
  • HIV-1
  • HIV Infections
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Haynes, B. F., Liao, H. X., Staats, H. F., Alam, M. S., Weinhold, K. J., & Montefiori, D. C. (2000). HIV vaccine development at Duke University Medical Center. Immunol Res, 22(2–3), 263–269. https://doi.org/10.1385/ir:22:2-3:263
Haynes, B. F., H. X. Liao, H. F. Staats, M. S. Alam, K. J. Weinhold, and D. C. Montefiori. “HIV vaccine development at Duke University Medical Center.Immunol Res 22, no. 2–3 (2000): 263–69. https://doi.org/10.1385/ir:22:2-3:263.
Haynes BF, Liao HX, Staats HF, Alam MS, Weinhold KJ, Montefiori DC. HIV vaccine development at Duke University Medical Center. Immunol Res. 2000;22(2–3):263–9.
Haynes, B. F., et al. “HIV vaccine development at Duke University Medical Center.Immunol Res, vol. 22, no. 2–3, 2000, pp. 263–69. Pubmed, doi:10.1385/ir:22:2-3:263.
Haynes BF, Liao HX, Staats HF, Alam MS, Weinhold KJ, Montefiori DC. HIV vaccine development at Duke University Medical Center. Immunol Res. 2000;22(2–3):263–269.
Journal cover image

Published In

Immunol Res

DOI

ISSN

0257-277X

Publication Date

2000

Volume

22

Issue

2-3

Start / End Page

263 / 269

Location

United States

Related Subject Headings

  • Vaccines, Synthetic
  • T-Lymphocytes, Cytotoxic
  • Peptide Fragments
  • North Carolina
  • Molecular Sequence Data
  • Immunology
  • Humans
  • HLA Antigens
  • HIV-1
  • HIV Infections